IPCA LABORATORIES LTD. - 524494 - 73Rd Annual General Meeting To Be Held On Thursday, 10Th August, 2023
73rd Annual General Meeting to be held on Thursday, 10th August, 202311-07-2023
11-07-2023
IPCA LABORATORIES LTD. - 524494 - Business Responsibility and Sustainability Reporting (BRSR)
Please find attached herewith the Business Responsibility and Sustainability Reporting forming part of the Annual Report of the Company for the financial year 2022-23. Kindly acknowledge the receipt.10-07-2023
IPCA LABORATORIES LTD. - 524494 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
In Compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, we are enclosing herewith a copy of the Certificate received from Link Intime India Pvt. Ltd., the Registrar and Share Transfer Agent of the Company, for the quarter ended June 30, 2023. Kindly acknowledge the receipt of the same.07-07-2023
IPCA LABORATORIES LTD. - 524494 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication05-07-2023
Ipca Lab may face the heat as USFDA issues Form 483 with 8 observations
The share touched a 52-week high of Rs 1,033.50 and a 52-week low of Rs 670 on 05 August, 2022 and 22 May, 2023, respectively.26-06-2023
IPCA LABORATORIES LTD. - 524494 - Inspection Of Company'S Formulations Manufacturing Facility Situated At SEZ Indore, Pithampur (Madhya Pradesh) By US FDA
Inspection of Company's formulations manufacturing facility situated at SEZ Indore, Pithampur (Madhya Pradesh) by US FDA23-06-2023
USFDA issues 11 observations following inspection of Ipca Labs facility in Ratlam
The company will submit a comprehensive response'on these observations to resolve the issues at the earliest14-06-2023
IPCA LABORATORIES LTD. - 524494 - Inspection Of Company'S Apis Manufacturing Facility Situated At Ratlam, Madhya Pradesh By US FDA
Inspection of Company's APIs manufacturing facility situated at Ratlam, Madhya Pradesh by US FDA14-06-2023